Diagnostics Market Research Reports & Industry Analysis

The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.

New Diagnostics Industry Reports Produced by Industry Experts

To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.

What Are the Benefits of Using MarketResearch.com?

  • At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
  • We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
  • Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
  • With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
...Show More ...Show Less


Diagnostics Industry Research & Market Reports

  • Circulating Tumor Cell (CTC) Diagnostics

    ... Billion by 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Detection & Enrichment, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$15.4 ... Read More

  • Vein Illumination Technologies

    ... at a CAGR of 29.1% over the analysis period 2024-2030. Intravenous Access, one of the segments analyzed in the report, is expected to record a 30.6% CAGR and reach US$931.4 Million by the end of ... Read More

  • X-Ray Detectors

    ... CAGR of 5.2% over the analysis period 2024-2030. Medical, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.8 Billion by the end of the analysis period. ... Read More

  • Medical Microbiology Testing Technologies

    ... 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Respiratory Diseases, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.4 Billion by the ... Read More

  • Refurbished Medical Imaging Equipment

    ... 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. CT Scanners, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$2.9 Billion by the ... Read More

  • Tuberculosis Testing

    ... CAGR of 4.9% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.4 Billion by the end of the analysis period. ... Read More

  • COVID-19 Testing

    ... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More

  • Microtomes

    ... 6.0% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$162.8 Million by the end of the analysis period. Growth in ... Read More

  • Pediatric Imaging

    ... CAGR of 7.1% over the analysis period 2024-2030. Magnetic Resonance Imaging, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$5.2 Billion by the end of the ... Read More

  • Point of Care (POC) Molecular Diagnostics

    ... reach US$8.8 Billion by 2030, growing at a CAGR of 12.9% over the analysis period 2024-2030. Infectious Diseases, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach ... Read More

  • In Vitro Diagnostics (IVD) Quality Control

    ... reach US$1.8 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Clinical Chemistry, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach ... Read More

  • Measuring Instrument Manufacturers & Suppliers (UK) - Industry Report

    ... heading for failure • Seek out the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Measuring Instrument Manufacturers & Suppliers ... Read More

  • Drug & Alcohol Testing (UK) - Industry Report

    ... failure • Seek out the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Drug & Alcohol Testing (UK) report will ... Read More

  • Medical Imaging Equipment Services

    ... 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. OEM, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$26.1 Billion by the end ... Read More

  • Breath Analyzers

    ... CAGR of 15.4% over the analysis period 2024-2030. Fuel Cells, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$2.6 Billion by the end of the analysis ... Read More

  • First Aid Kits

    ... at a CAGR of 6.2% over the analysis period 2024-2030. Common Type Kit, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$189.1 Million by the end ... Read More

  • Computed Tomography (CT) Scanners

    ... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. High-End Slice, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.5 Billion by the ... Read More

  • Fetal Monitoring

    ... CAGR of 6.1% over the analysis period 2024-2030. Ultrasound Systems, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.9 Billion by the end of the analysis ... Read More

  • Mammography Equipment

    ... CAGR of 6.8% over the analysis period 2024-2030. 2-D Digital Mammography Systems, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$2.1 Billion by the end of ... Read More

  • Ovulation Test

    ... CAGR of 4.0% over the analysis period 2024-2030. Urine, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis period. ... Read More

  • Biochemistry Analyzers

    ... CAGR of 5.4% over the analysis period 2024-2030. Clinical Diagnostics Application, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$6.4 Billion by the end of the ... Read More

  • Laboratory Automated Incubators

    ... at a CAGR of 4.0% over the analysis period 2024-2030. Pharma & Biotech Companies, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$399.4 Million by the ... Read More

  • Autoimmune Disease Diagnosis

    ... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More

  • Blood Banking and Blood Products

    ... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Blood Components & Plasma Products, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and ... Read More

  • Carrier Screening

    ... CAGR of 15.6% over the analysis period 2024-2030. Molecular Screening Test, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$5.5 Billion by the end of the ... Read More

Cookie Settings